Protalix to propose virtual inspection to clear barrier to FDA approval

Protalix to propose virtual inspection to clear barrier to FDA approval

Submitted by admin on May 20, 2021 - 11:10am
Source: 
Biopharma Reporter
News Tags: 
Protalix BioTherapeutics
Chiesi Farmaceutica
Fabry disease
FDA
Headline: 
Protalix to propose virtual inspection to clear barrier to FDA approval
snippet: 

Protalix BioTherapeutics is planning to propose a virtual or record review inspection to clear the barrier to approval of its Chiesi Farmaceutici-partnered Fabry disease treatment.

Do Not Allow Advertisers to Use My Personal information